Sponsor or institution
Clinical trials and research at Tridem Bioscience FlexCo
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Tridem Bioscience FlexCo that are recruiting, in Austria. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
TRB-001 safety and immune response in early Parkinson's disease
This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.
-
TRB-001 vaccination in Parkinson's disease: safety and biological effects in a small, single-arm study
This pilot trial tests TRB-001 vaccination in adults with Parkinson's who previously had active aSyn immunotherapy to see if it is safe and tolerable and to explore immune responses and biological effects.
Quick answers
How many clinical trials run by Tridem Bioscience FlexCo are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Austria. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.